| Literature DB >> 2214477 |
B Saito1, T Ohashi, M Togashi, T Koyanagi.
Abstract
To evaluate the genetic difference in induction of bladder cancer by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN), BBN was given to two different strains of mice, i.e. A/J (BCG resistant) strains and C57BL/6 (BCG susceptible) strains. The influence of Freund complete adjuvant (FCA), which includes BCG, was similarly examined along with associated cellular immunity as evaluated by footpad reaction (FPR). The results were as follows: 1. The incidence of bladder cancer was significantly higher in C57BL/6 strains (90.0%) than A/J strains (54.5%). 2. FCA reduced the incidence of bladder cancer significantly in C57BL/6 strains. 3. FPR, which reflects the delayed type hypersensitivity, was activated significantly in FCA treated C57BL/6 strains. These data suggest that the strain differences in mice probably explains the inhibition of carcinogenesis by FCA and cellular immunity.Entities:
Mesh:
Substances:
Year: 1990 PMID: 2214477 DOI: 10.5980/jpnjurol1989.81.993
Source DB: PubMed Journal: Nihon Hinyokika Gakkai Zasshi ISSN: 0021-5287